跳至主要内容
临床试验/IRCT201102273449N4
IRCT201102273449N4已完成未知

Efficacy of topical formulation of Atorvastatin 1% in bed sore healing

Pharmaceutical Research Center, Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Grade 1 or 2 bed sore diagnosed by the pharmacist according to The 2-digit Stirling scale
  • Exclusion criteria: pregnancy or lactation, hypersensitivity reaction to topical formulation, elevated ALT and/or AST to more than 3 times the upper limit of normal with clinical manifestations of liver failure or more than 5 times the upper limit of normal without clinical manifestations of liver failure, unwillingness for entering in the study or discontinuation of follow up

排除标准

  • 未提供

研究者

发起方
Pharmaceutical Research Center, Tehran University of Medical Sciences

相似试验